Muhammad Omar Chohan
Overview
Explore the profile of Muhammad Omar Chohan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
404
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang W, Kumm Z, Ho C, Zanesco-Fontes I, Texiera G, Reis R, et al.
Neurooncol Adv
. 2024 Feb;
6(1):vdad140.
PMID: 38405202
Background: Glioblastoma is a malignant brain tumor requiring careful clinical monitoring even after primary management. Personalized medicine has suggested the use of various molecular biomarkers as predictors of patient prognosis...
2.
Chohan M, Flores R, Wertz C, Jung R
PLoS One
. 2024 Feb;
19(2):e0284261.
PMID: 38300915
Supratotal resection of primary brain tumors is being advocated especially when involving "non-eloquent" tissue. However, there is extensive neuropsychological data implicating functions critical to higher cognition in areas considered "non-eloquent"...
3.
Kazim S, Martinez E, Hough T, Spangler B, Bowers C, Chohan M
Front Neurol
. 2021 Feb;
12:615593.
PMID: 33613432
Glioblastoma multiforme (GBM), the most common malignant brain tumor, universally carries a poor prognosis. Despite aggressive multimodality treatment, the median survival is ~18-20 months, depending on molecular subgroups. A long...
4.
Necessity of brain imaging in COVID-19 infected patients presenting with acute neurological deficits
Mohammad L, Botros J, Chohan M
Interdiscip Neurosurg
. 2020 Aug;
22:100883.
PMID: 32835024
Background: Patients undergoing cardiopulmonary stabilization in the intensive care unit for novel coronavirus (COVID-19) are often sedated, placing timely assessment of a neurological decline at risk. Case Description: Here, we...
5.
Chohan M, Berger M
J Neurooncol
. 2018 Aug;
141(3):517-522.
PMID: 30097823
Introduction: Fluorescence guided surgery (FGS) with five-aminolevulinic acid (5-ALA) is expected to revolutionize neurosurgical care of patients with high-grade gliomas (HGG). After the recent landmark FDA approval, this optical agent...
6.
Chohan M, Carlson A, Murray-Krezan C, Taylor C, Yonas H
Can J Neurol Sci
. 2017 Aug;
44(4):410-414.
PMID: 28767031
Background: The role of aggressive surgical manipulation with clot evacuation, arachnoid dissection, and papaverine-guided adventitial dissection of large vessels during ruptured aneurysm surgery in reducing vasospasm is controversial. Here we...
7.
Chohan M, Kahn S, Cederquist G, Reiner A, Schwab J, Laufer I, et al.
Neurosurgery
. 2017 May;
82(5):670-677.
PMID: 28541420
Background: Spine and nonspine skeletal metastases occur in more than 80% of patients with prostate cancer. Objective: To examine the characteristics of the patient population undergoing surgery for the treatment...
8.
Chohan M, Levin A, Singh R, Zhou Z, Green C, Kazam J, et al.
Pituitary
. 2016 Feb;
19(3):311-21.
PMID: 26843023
Purpose: Maximum two-dimensional (2D) diameter has been used to define giant pituitary adenoma (GPA) surgery outcomes as has volume using an ellipsoid approximation of volumetrics. Cross sectional length can be...
9.
Chohan M, Bragina O, Kazim S, Statom G, Baazaoui N, Bragin D, et al.
Neurosurgery
. 2014 Sep;
76(2):201-14.
PMID: 25255260
Background: Traumatic brain injury (TBI) is a risk factor for Alzheimer disease (AD), a neurocognitive disorder with similar cellular abnormalities. We recently discovered a small molecule (Peptide 6) corresponding to...
10.
Chohan M, Akbik O, Ramos-Canseco J, Ramirez P, Murray-Krezan C, Berlin T, et al.
Neurosurgery
. 2014 Jun;
10 Suppl 3:400-11.
PMID: 24887290
Background: Multimodal intracranial monitoring in the neurosurgical patient requires insertion of probes through multiple craniostomies. Objective: To report our 5-year experience with a novel device allowing multimodal monitoring though a...